Showing results (51-60 of 1,631) with videos related to
Sort By:
Pageof 164
Deutsche Medizinische Wochenschrift (1946)|October 2, 1987
[Incidence of parvovirus B19 infection. Seroepidemiologic studies]T F Schwarz, M Roggendorf, F DeinhardtJournal of Virological Methods|June 1, 1988
Human parvovirus B19: ELISA and immunoblot assaysT F Schwarz, M Roggendorf, F DeinhardtJournal of Immunology (Baltimore, Md. : 1950)|May 1, 1979
Lymphocyte activation by the tumor-promoting agent 12-O-tetradecanoylphorbol-13-acetate (TPA)J Abb, G J Bayliss, F DeinhardtRevista Argentina De Microbiologia|January 1, 1982
[Lymphocyte heterogeneity of the T system: characterization of an allotypic antiserum recognizing a sub-species antigenic determinant in non-human primates]A Schudel, L A Falk, F DeinhardtVirology|December 1, 1986
Characterization of hepatitis A virus structural proteinsV Gauss-Müller, F Lottspeich, F DeinhardtDeutsche Medizinische Wochenschrift (1946)|February 8, 1985
[Persistence of antibodies against hepatitis B surface antigens after vaccination against hepatitis B]W Jilg, M Schmidt, R Zachoval, et al.Journal of Medical Virology|January 1, 1984
Evaluation of a reduced dose of hepatitis B vaccine administered intradermallyG Zoulek, B Lorbeer, W Jilg, et al.Primates in Medicine|January 1, 1978
Oncogenicity of the C-type virus HL-23V in marmosets and characterization of virus isolated from an HL-23V-induced marmoset tumor: comparison with simian sarcoma virus type 1C M Bergholz, L G Wolfe, F DeinhardtJournal of Medical Virology|January 1, 1981
Propagation of hepatitis A virus in human embryo fibroblastsV Gauss-Müller, G G Frösner, F DeinhardtJournal of Medical Virology|March 1, 1985
Demonstration of a transient rheumatoid factor in the acute phase of hepatitis non A, non BM Roggendorf, F Deinhardt, B Böhm, et al.Pageof 164